Growth Hormone Disorders Completed Phase 2 Trials for Somatropin pegol (DB15112)

Also known as: Growth Hormone Disorder

IndicationStatusPhase
DBCOND0036845 (Growth Hormone Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00936403A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth HormoneTreatment
NCT00715689Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083Treatment